PSC
SRPT icon

Prentiss Smith & Co’s Sarepta Therapeutics SRPT Stock Holding History

Prentiss Smith & Co’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-722
Closed -$117K – 204
2018
Q3 		$117K Hold
722
– – 0.07% 79
2018
Q2 		$95K Sell
722
-3,166
-81% -$299K 0.06% 87
2018
Q1 		$288K Buy
3,888
+312
+9% +$20.8K 0.15% 67
2017
Q4 		$199K Sell
3,576
-312
-8% -$16.5K 0.1% 72
2017
Q3 		$176K Buy
3,888
+312
+9% +$12.5K 0.1% 65
2017
Q2 		$121K Buy
3,576
+3,166
+772% +$103K 0.06% 83
2017
Q1 		$12K Hold
410
– – 0.01% 186
2016
Q4 		$11K Hold
410
– – 0.01% 198
2016
Q3 		$25K Hold
410
– – 0.01% 161
2016
Q2 		$8K Hold
410
– – ﹤0.01% 223
2016
Q1 		$8K Buy
+410
New +$7.16K ﹤0.01% 248

Other funds holding SRPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return